Fampyra

Biogen returns ex-U.S. rights of MS drug Fampyra to Acorda
Fierce Pharma
Thu, 01/11/24 - 08:45 pm
Biogen
Fampyra
MS
multiple sclerosis
Acorda Therapeutics
Is Biogen Too Good To Be True?
Seeking Alpha
Tue, 09/18/12 - 04:44 pm
BiogenIdec
Avonex
Tysabri
Fampyra
Fumaderm
New Data Presented at 64th AAN Annual Meeting Highlights Biogen Idec’s Commitment to Deliver Promising Therapies for Unmet Needs in Neurodegenerative Diseases
Yahoo/BusinessWire
Sat, 04/21/12 - 11:49 am
Biogen
Tysabri
Fampyra
BG-12
multiple sclerosis
amyotrophic lateral sclerosis
DAC HYP
Biogen's Fampyra Launched in Canada
Yahoo/Zacks
Sat, 04/14/12 - 12:39 pm
Biogen Idec
Fampyra
multiple sclerosis
Biogen wins conditional EU approval for MS drug
Bizjournals.com
Mon, 07/25/11 - 10:25 am
Biogen Idec
Europe
MS
multiple sclerosis
Fampyra
CHMP Backs Biogen's Fampyra
Yahoo/Zacks.com
Tue, 05/24/11 - 08:28 am
Biogen Idec
Fampyra
CHMP
MS
multiple sclerosis
The Big Winner of the EU Drug Approval Bonanza
Motley Fool
Sat, 05/21/11 - 11:05 am
Benlysta
Human Genome Sciences
Vibativ
Theravance
GSK
Victrelis
Merck
Xgeva
Amgen
Yervoy
Bristol-Myers Squibb
Fampyra
Acorda Therapeutics
Biogen Idec
Acorda, Biogen fall on EU drug rejection
Marketwatch
Fri, 01/21/11 - 10:13 am
Acorda Therapeutics
Europe
Biogen Idec
Fampyra
MS
multiple sclerosis